Bright Minds Biosciences Inc. · CSE:DRUG
Vestal Point Capital, LP reported a 5.00% stake in Bright Minds Biosciences Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 15, 2026
Vestal Point Capital, LP reported a 5.00% stake in Bright Minds Biosciences Inc., 492,319 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 492,319
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vestal Point Capital, LP | 5.00% | 492,319 |
| Ryan Wilder | 5.00% | 492,319 |
Source
Related
- Bright Minds Biosciences Inc.
- Vestal Point Capital, LP
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026